Your browser doesn't support javascript.
loading
Exosomes derived from TGF-ß1-pretreated mesenchymal stem cells alleviate biliary ischemia-reperfusion injury through Jagged1/Notch1/SOX9 pathway.
Yasen, Aimaiti; Feng, Jun; Xie, Xing-Ming; Li, Kai; Cai, Yu-Hong; Liao, Zhi-Hong; Liang, Run-Bin; Dai, Tian-Xing; Wang, Guo-Ying.
Afiliación
  • Yasen A; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China. Electronic address: 2021390035@gzhmu.edu.cn.
  • Feng J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
  • Xie XM; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China. Electronic address: xiexingming83@aliyun.com.
  • Li K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
  • Cai YH; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
  • Liao ZH; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
  • Liang RB; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China. Electronic address: 2021390069@gzhmu.edu.cn.
  • Dai TX; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
  • Wang GY; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China. Electronic address: wanggy3@126.com.
Int Immunopharmacol ; 119: 110253, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37156030

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Daño por Reperfusión / Exosomas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Daño por Reperfusión / Exosomas / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article